Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors

The quinone binding site (Q-site) of Mitochondrial Complex II (succinate-ubiquinone oxidoreductase) is the target for a number of inhibitors useful for elucidating the mechanism of the enzyme. Some of these have been developed as fungicides or pesticides, and species-specific Q-site inhibitors may b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochimica et biophysica acta. Proteins and proteomics 2021-09, Vol.1869 (9), p.140679-140679, Article 140679
Hauptverfasser: Huang, Li-shar, Lümmen, Peter, Berry, Edward A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 140679
container_issue 9
container_start_page 140679
container_title Biochimica et biophysica acta. Proteins and proteomics
container_volume 1869
creator Huang, Li-shar
Lümmen, Peter
Berry, Edward A.
description The quinone binding site (Q-site) of Mitochondrial Complex II (succinate-ubiquinone oxidoreductase) is the target for a number of inhibitors useful for elucidating the mechanism of the enzyme. Some of these have been developed as fungicides or pesticides, and species-specific Q-site inhibitors may be useful against human pathogens. We report structures of chicken Complex II with six different Q-site inhibitors bound, at resolutions 2.0–2.4 Å. These structures show the common interactions between the inhibitors and their binding site. In every case a carbonyl or hydroxyl oxygen of the inhibitor is H-bonded to Tyr58 in subunit SdhD and Trp173 in subunit SdhB. Two of the inhibitors H-bond Ser39 in subunit SdhC directly, while two others do so via a water molecule. There is a distinct cavity that accepts the 2-substituent of the carboxylate ring in flutolanil and related inhibitors. A hydrophobic “tail pocket” opens to receive a side-chain of intermediate-length inhibitors. Shorter inhibitors fit entirely within the main binding cleft, while the long hydrophobic side chains of ferulenol and atpenin A5 protrude out of the cleft into the bulk lipid region, as presumably does that of ubiquinone. Comparison of mitochondrial and Escherichia coli Complex II shows a rotation of the membrane-anchor subunits by 7° relative to the iron‑sulfur protein. This rotation alters the geometry of the Q-site and the H-bonding pattern of SdhB:His216 and SdhD:Asp57. This conformational difference, rather than any active-site mutation, may be responsible for the different inhibitor sensitivity of the bacterial enzyme. [Display omitted] •Structurally diverse molecules are known to inhibit the quinone-reducing site (Q-site).•SQR Q-site inhibitors are investigative tools, pesticides, and potential therapeutics.•We used x-ray crystallography to determine the binding mode of six Q-site inhibitors.•The inhibitors share certain universal binding features but differ in specific features.•Vertebrate and E. coli SQR differ in orientation of SDHB to the membrane subunits.
doi_str_mv 10.1016/j.bbapap.2021.140679
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8516616</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1570963921000856</els_id><sourcerecordid>34089891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-44e8864e208e4986c27ffe529843d60379fa65a491cd92480521ecb285d1c3913</originalsourceid><addsrcrecordid>eNp9kN1qGzEQhUVJaX7aNyhBL7COpNVqpZtAMGlrCPSmvRZa7aw9Zi1tJNnEb981btP0plczcDjnzHyEfOZswRlXd9tF17nJTQvBBF9wyVRr3pErrltdcdnIi3lvWlYZVZtLcp3zljHB2rb5QC5rybTRhl-R7TIdc3HjGNfJTRv0FMMBcsG1KxgDjQMtG6D7Dp_3GGIA2mHoMaxpxgInOUGeMLkS05Eu424a4YWuVtSFnmLJc9wGO5zV_JG8H9yY4dPveUN-fnn8sfxWPX3_ulo-PFW-EaZUUoLWSoJgGqTRyot2GGCWtKx7xerWDE41ThrueyOkZo3g4Duhm5772vD6htyfc6d9t4PeQyjJjXZKuHPpaKND-68ScGPX8WB1w5Xiag6Q5wCfYs4JhlcvZ_bE3m7tmb09sbdn9rPt9m3vq-kP7L-Hwfz9ASHZ7BGChx4T-GL7iP9v-AW8zJnw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Huang, Li-shar ; Lümmen, Peter ; Berry, Edward A.</creator><creatorcontrib>Huang, Li-shar ; Lümmen, Peter ; Berry, Edward A.</creatorcontrib><description>The quinone binding site (Q-site) of Mitochondrial Complex II (succinate-ubiquinone oxidoreductase) is the target for a number of inhibitors useful for elucidating the mechanism of the enzyme. Some of these have been developed as fungicides or pesticides, and species-specific Q-site inhibitors may be useful against human pathogens. We report structures of chicken Complex II with six different Q-site inhibitors bound, at resolutions 2.0–2.4 Å. These structures show the common interactions between the inhibitors and their binding site. In every case a carbonyl or hydroxyl oxygen of the inhibitor is H-bonded to Tyr58 in subunit SdhD and Trp173 in subunit SdhB. Two of the inhibitors H-bond Ser39 in subunit SdhC directly, while two others do so via a water molecule. There is a distinct cavity that accepts the 2-substituent of the carboxylate ring in flutolanil and related inhibitors. A hydrophobic “tail pocket” opens to receive a side-chain of intermediate-length inhibitors. Shorter inhibitors fit entirely within the main binding cleft, while the long hydrophobic side chains of ferulenol and atpenin A5 protrude out of the cleft into the bulk lipid region, as presumably does that of ubiquinone. Comparison of mitochondrial and Escherichia coli Complex II shows a rotation of the membrane-anchor subunits by 7° relative to the iron‑sulfur protein. This rotation alters the geometry of the Q-site and the H-bonding pattern of SdhB:His216 and SdhD:Asp57. This conformational difference, rather than any active-site mutation, may be responsible for the different inhibitor sensitivity of the bacterial enzyme. [Display omitted] •Structurally diverse molecules are known to inhibit the quinone-reducing site (Q-site).•SQR Q-site inhibitors are investigative tools, pesticides, and potential therapeutics.•We used x-ray crystallography to determine the binding mode of six Q-site inhibitors.•The inhibitors share certain universal binding features but differ in specific features.•Vertebrate and E. coli SQR differ in orientation of SDHB to the membrane subunits.</description><identifier>ISSN: 1570-9639</identifier><identifier>EISSN: 1878-1454</identifier><identifier>DOI: 10.1016/j.bbapap.2021.140679</identifier><identifier>PMID: 34089891</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Active site ; Amino Acid Sequence - genetics ; Animals ; Benzoquinones ; Binding Sites ; Chickens - genetics ; Electron Transport Complex II - antagonists &amp; inhibitors ; Electron Transport Complex II - metabolism ; Electron Transport Complex II - ultrastructure ; Ligand binding ; Membrane protein ; Multienzyme Complexes - genetics ; Multienzyme Complexes - metabolism ; Mutagenesis, Site-Directed ; Oxidoreductase ; Protein structure ; Quinones - chemistry ; Sequence Alignment ; Succinate-quinone reductase ; Sus scrofa - genetics ; Ubiquinone ; Ubiquinone - chemistry ; Ubiquinone - ultrastructure ; X-ray crystallography</subject><ispartof>Biochimica et biophysica acta. Proteins and proteomics, 2021-09, Vol.1869 (9), p.140679-140679, Article 140679</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-44e8864e208e4986c27ffe529843d60379fa65a491cd92480521ecb285d1c3913</citedby><cites>FETCH-LOGICAL-c529t-44e8864e208e4986c27ffe529843d60379fa65a491cd92480521ecb285d1c3913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1570963921000856$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34089891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Li-shar</creatorcontrib><creatorcontrib>Lümmen, Peter</creatorcontrib><creatorcontrib>Berry, Edward A.</creatorcontrib><title>Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors</title><title>Biochimica et biophysica acta. Proteins and proteomics</title><addtitle>Biochim Biophys Acta Proteins Proteom</addtitle><description>The quinone binding site (Q-site) of Mitochondrial Complex II (succinate-ubiquinone oxidoreductase) is the target for a number of inhibitors useful for elucidating the mechanism of the enzyme. Some of these have been developed as fungicides or pesticides, and species-specific Q-site inhibitors may be useful against human pathogens. We report structures of chicken Complex II with six different Q-site inhibitors bound, at resolutions 2.0–2.4 Å. These structures show the common interactions between the inhibitors and their binding site. In every case a carbonyl or hydroxyl oxygen of the inhibitor is H-bonded to Tyr58 in subunit SdhD and Trp173 in subunit SdhB. Two of the inhibitors H-bond Ser39 in subunit SdhC directly, while two others do so via a water molecule. There is a distinct cavity that accepts the 2-substituent of the carboxylate ring in flutolanil and related inhibitors. A hydrophobic “tail pocket” opens to receive a side-chain of intermediate-length inhibitors. Shorter inhibitors fit entirely within the main binding cleft, while the long hydrophobic side chains of ferulenol and atpenin A5 protrude out of the cleft into the bulk lipid region, as presumably does that of ubiquinone. Comparison of mitochondrial and Escherichia coli Complex II shows a rotation of the membrane-anchor subunits by 7° relative to the iron‑sulfur protein. This rotation alters the geometry of the Q-site and the H-bonding pattern of SdhB:His216 and SdhD:Asp57. This conformational difference, rather than any active-site mutation, may be responsible for the different inhibitor sensitivity of the bacterial enzyme. [Display omitted] •Structurally diverse molecules are known to inhibit the quinone-reducing site (Q-site).•SQR Q-site inhibitors are investigative tools, pesticides, and potential therapeutics.•We used x-ray crystallography to determine the binding mode of six Q-site inhibitors.•The inhibitors share certain universal binding features but differ in specific features.•Vertebrate and E. coli SQR differ in orientation of SDHB to the membrane subunits.</description><subject>Active site</subject><subject>Amino Acid Sequence - genetics</subject><subject>Animals</subject><subject>Benzoquinones</subject><subject>Binding Sites</subject><subject>Chickens - genetics</subject><subject>Electron Transport Complex II - antagonists &amp; inhibitors</subject><subject>Electron Transport Complex II - metabolism</subject><subject>Electron Transport Complex II - ultrastructure</subject><subject>Ligand binding</subject><subject>Membrane protein</subject><subject>Multienzyme Complexes - genetics</subject><subject>Multienzyme Complexes - metabolism</subject><subject>Mutagenesis, Site-Directed</subject><subject>Oxidoreductase</subject><subject>Protein structure</subject><subject>Quinones - chemistry</subject><subject>Sequence Alignment</subject><subject>Succinate-quinone reductase</subject><subject>Sus scrofa - genetics</subject><subject>Ubiquinone</subject><subject>Ubiquinone - chemistry</subject><subject>Ubiquinone - ultrastructure</subject><subject>X-ray crystallography</subject><issn>1570-9639</issn><issn>1878-1454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kN1qGzEQhUVJaX7aNyhBL7COpNVqpZtAMGlrCPSmvRZa7aw9Zi1tJNnEb981btP0plczcDjnzHyEfOZswRlXd9tF17nJTQvBBF9wyVRr3pErrltdcdnIi3lvWlYZVZtLcp3zljHB2rb5QC5rybTRhl-R7TIdc3HjGNfJTRv0FMMBcsG1KxgDjQMtG6D7Dp_3GGIA2mHoMaxpxgInOUGeMLkS05Eu424a4YWuVtSFnmLJc9wGO5zV_JG8H9yY4dPveUN-fnn8sfxWPX3_ulo-PFW-EaZUUoLWSoJgGqTRyot2GGCWtKx7xerWDE41ThrueyOkZo3g4Duhm5772vD6htyfc6d9t4PeQyjJjXZKuHPpaKND-68ScGPX8WB1w5Xiag6Q5wCfYs4JhlcvZ_bE3m7tmb09sbdn9rPt9m3vq-kP7L-Hwfz9ASHZ7BGChx4T-GL7iP9v-AW8zJnw</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Huang, Li-shar</creator><creator>Lümmen, Peter</creator><creator>Berry, Edward A.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20210901</creationdate><title>Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors</title><author>Huang, Li-shar ; Lümmen, Peter ; Berry, Edward A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-44e8864e208e4986c27ffe529843d60379fa65a491cd92480521ecb285d1c3913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Active site</topic><topic>Amino Acid Sequence - genetics</topic><topic>Animals</topic><topic>Benzoquinones</topic><topic>Binding Sites</topic><topic>Chickens - genetics</topic><topic>Electron Transport Complex II - antagonists &amp; inhibitors</topic><topic>Electron Transport Complex II - metabolism</topic><topic>Electron Transport Complex II - ultrastructure</topic><topic>Ligand binding</topic><topic>Membrane protein</topic><topic>Multienzyme Complexes - genetics</topic><topic>Multienzyme Complexes - metabolism</topic><topic>Mutagenesis, Site-Directed</topic><topic>Oxidoreductase</topic><topic>Protein structure</topic><topic>Quinones - chemistry</topic><topic>Sequence Alignment</topic><topic>Succinate-quinone reductase</topic><topic>Sus scrofa - genetics</topic><topic>Ubiquinone</topic><topic>Ubiquinone - chemistry</topic><topic>Ubiquinone - ultrastructure</topic><topic>X-ray crystallography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Li-shar</creatorcontrib><creatorcontrib>Lümmen, Peter</creatorcontrib><creatorcontrib>Berry, Edward A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochimica et biophysica acta. Proteins and proteomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Li-shar</au><au>Lümmen, Peter</au><au>Berry, Edward A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors</atitle><jtitle>Biochimica et biophysica acta. Proteins and proteomics</jtitle><addtitle>Biochim Biophys Acta Proteins Proteom</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>1869</volume><issue>9</issue><spage>140679</spage><epage>140679</epage><pages>140679-140679</pages><artnum>140679</artnum><issn>1570-9639</issn><eissn>1878-1454</eissn><abstract>The quinone binding site (Q-site) of Mitochondrial Complex II (succinate-ubiquinone oxidoreductase) is the target for a number of inhibitors useful for elucidating the mechanism of the enzyme. Some of these have been developed as fungicides or pesticides, and species-specific Q-site inhibitors may be useful against human pathogens. We report structures of chicken Complex II with six different Q-site inhibitors bound, at resolutions 2.0–2.4 Å. These structures show the common interactions between the inhibitors and their binding site. In every case a carbonyl or hydroxyl oxygen of the inhibitor is H-bonded to Tyr58 in subunit SdhD and Trp173 in subunit SdhB. Two of the inhibitors H-bond Ser39 in subunit SdhC directly, while two others do so via a water molecule. There is a distinct cavity that accepts the 2-substituent of the carboxylate ring in flutolanil and related inhibitors. A hydrophobic “tail pocket” opens to receive a side-chain of intermediate-length inhibitors. Shorter inhibitors fit entirely within the main binding cleft, while the long hydrophobic side chains of ferulenol and atpenin A5 protrude out of the cleft into the bulk lipid region, as presumably does that of ubiquinone. Comparison of mitochondrial and Escherichia coli Complex II shows a rotation of the membrane-anchor subunits by 7° relative to the iron‑sulfur protein. This rotation alters the geometry of the Q-site and the H-bonding pattern of SdhB:His216 and SdhD:Asp57. This conformational difference, rather than any active-site mutation, may be responsible for the different inhibitor sensitivity of the bacterial enzyme. [Display omitted] •Structurally diverse molecules are known to inhibit the quinone-reducing site (Q-site).•SQR Q-site inhibitors are investigative tools, pesticides, and potential therapeutics.•We used x-ray crystallography to determine the binding mode of six Q-site inhibitors.•The inhibitors share certain universal binding features but differ in specific features.•Vertebrate and E. coli SQR differ in orientation of SDHB to the membrane subunits.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34089891</pmid><doi>10.1016/j.bbapap.2021.140679</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1570-9639
ispartof Biochimica et biophysica acta. Proteins and proteomics, 2021-09, Vol.1869 (9), p.140679-140679, Article 140679
issn 1570-9639
1878-1454
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8516616
source MEDLINE; Elsevier ScienceDirect Journals
subjects Active site
Amino Acid Sequence - genetics
Animals
Benzoquinones
Binding Sites
Chickens - genetics
Electron Transport Complex II - antagonists & inhibitors
Electron Transport Complex II - metabolism
Electron Transport Complex II - ultrastructure
Ligand binding
Membrane protein
Multienzyme Complexes - genetics
Multienzyme Complexes - metabolism
Mutagenesis, Site-Directed
Oxidoreductase
Protein structure
Quinones - chemistry
Sequence Alignment
Succinate-quinone reductase
Sus scrofa - genetics
Ubiquinone
Ubiquinone - chemistry
Ubiquinone - ultrastructure
X-ray crystallography
title Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T06%3A37%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Crystallographic%20investigation%20of%20the%20ubiquinone%20binding%20site%20of%20respiratory%20Complex%20II%20and%20its%20inhibitors&rft.jtitle=Biochimica%20et%20biophysica%20acta.%20Proteins%20and%20proteomics&rft.au=Huang,%20Li-shar&rft.date=2021-09-01&rft.volume=1869&rft.issue=9&rft.spage=140679&rft.epage=140679&rft.pages=140679-140679&rft.artnum=140679&rft.issn=1570-9639&rft.eissn=1878-1454&rft_id=info:doi/10.1016/j.bbapap.2021.140679&rft_dat=%3Cpubmed_cross%3E34089891%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34089891&rft_els_id=S1570963921000856&rfr_iscdi=true